EcoDrugPlus

Amine Oxidase Copper Containing 2

Ensembl ID : ENSATEG00000010046
Gene Symbol: AOC2
2 Cross references
403 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSATEG00000010686
Gene Symbol: APPB
2 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSATEG00000002720
Gene Symbol: APP
4 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSATEG00000011237
Gene Symbol: AR
1 Cross references
214 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSATEG00000020070
Gene Symbol: LOC113160176
2 Cross references
205 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSATEG00000006900
Gene Symbol: AGTR1
3 Cross references
203 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSATEG00000014943
Gene Symbol: LOC113163585
2 Cross references
142 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSATEG00000003520
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSATEG00000001548
Gene Symbol: ALOX5A
1 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSATEG00000026021
Gene Symbol: ALOX5AP
3 Cross references
201 Possible Orthologues:

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSATEG00000021393
Gene Symbol: LOC113163962
2 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 1aa

Ensembl ID : ENSATEG00000020285
Gene Symbol: AVPR1AA
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).